MRI for non-cancer lung diseases
Part of Lungs & breathing clinical trials.
This study uses MRI scans to look at the lungs of people with early-stage IPF, a lung scarring disease. It aims to see how well MRI can show lung changes without using radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with early-stage idiopathic pulmonary fibrosis (IPF), a type of lung scarring.
- You do not have any metal implants or devices that would make an MRI unsafe.
- You do not have any conditions that would make a lung washing (bronchoalveolar lavage) risky for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced imaging to see how immunosuppressive medications (like mycophenolate or prednisone) affect lung scarring in patients with certain types of lung fibrosis. You would have imaging scans and breathing tests to track changes over time.
This Phase 2 study uses a special type of MRI with inhaled gas to measure how well your lungs work. It may help researchers better understand lung function in healthy people and in people with lung disease.
This trial uses a special PET/MRI scan to look for early signs of lung scarring and inflammation using a “collagen-targeting” tracer. It may help doctors better identify early interstitial lung disease (IL D) and track it over time.
This study looks at what factors contribute to worsening lung scarring seen on scans in people with certain lung diseases. Results may help doctors better understand and predict who will worsen over time.
This trial uses advanced lung MRI scans to get more detail on tumors and lymph nodes. It may help people with non-small cell lung cancer to get a clearer picture of their cancer stage without extra radiation.
This study uses MRI scans to monitor how lung scarring changes over time in people with certain types of interstitial lung disease (ILD), like idiopathic pulmonary fibrosis (IPF). The goal is to see if MRI can be a helpful tool for tracking the disease without needing as many CT scans.
Hear when a new Interstitial Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.